IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.

PubWeight™: 7.00‹?› | Rank: Top 1%

🔗 View Article (PMC 2760130)

Published in Nature on May 11, 2008

Authors

Li Yang1, David E Anderson, Clare Baecher-Allan, William D Hastings, Estelle Bettelli, Mohamed Oukka, Vijay K Kuchroo, David A Hafler

Author Affiliations

1: Division of Molecular Immunology, Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Articles citing this

(truncated to the top 100)

Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 9.73

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature (2008) 8.22

TGFβ signalling in context. Nat Rev Mol Cell Biol (2012) 8.08

CD4 T cells: fates, functions, and faults. Blood (2008) 7.03

Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity (2009) 6.87

Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol (2009) 4.98

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood (2009) 4.80

Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol (2009) 4.69

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature (2013) 4.57

Control of TH17 cells occurs in the small intestine. Nature (2011) 4.03

Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest (2008) 3.90

Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol (2008) 3.88

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med (2008) 3.85

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature (2012) 3.85

The microbiome in infectious disease and inflammation. Annu Rev Immunol (2012) 3.76

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65

T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol (2010) 3.39

Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal (2009) 3.19

IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood (2009) 3.04

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol (2010) 2.94

A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity (2009) 2.59

A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med (2010) 2.53

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol (2011) 2.53

Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol (2009) 2.48

Retracted Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med (2010) 2.43

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci U S A (2008) 2.33

Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol (2009) 2.12

A rush to judgment on Th17. J Exp Med (2008) 2.07

The role of NKT cells in tumor immunity. Adv Cancer Res (2008) 2.05

IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol (2009) 2.00

TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol (2009) 2.00

Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol (2010) 1.99

Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. Immunity (2011) 1.98

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol (2010) 1.98

Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol (2009) 1.95

The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med (2009) 1.95

TH-17 cells in rheumatoid arthritis. Arthritis Res Ther (2008) 1.93

Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther (2010) 1.93

The effects of IL-6 on CD4 T cell responses. Clin Immunol (2008) 1.90

Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol (2009) 1.90

Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med (2009) 1.89

IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H). J Clin Invest (2009) 1.87

The many faces of Th17 cells. Curr Opin Immunol (2011) 1.84

Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J Immunol (2009) 1.83

IL-17 induces monocyte migration in rheumatoid arthritis. J Immunol (2009) 1.82

Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2010) 1.78

Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol (2009) 1.78

The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol (2010) 1.78

Th17 cells: from precursors to players in inflammation and infection. Int Immunol (2009) 1.77

IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol (2009) 1.77

IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol (2010) 1.73

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol (2012) 1.71

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70

Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol (2010) 1.70

IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol (2012) 1.68

From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev (2008) 1.65

Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice. J Clin Invest (2010) 1.63

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3. Immunity (2013) 1.62

Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev (2010) 1.61

Follicular helper T cell signature in type 1 diabetes. J Clin Invest (2014) 1.61

The Th17 family: flexibility follows function. Immunol Rev (2013) 1.58

Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol (2009) 1.56

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A (2010) 1.56

Regulating human Th17 cells via differential expression of IL-1 receptor. Blood (2009) 1.54

Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol Rev (2008) 1.54

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion. Nat Med (2012) 1.48

gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48

Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47

T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol (2011) 1.47

Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS (2010) 1.45

Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther (2009) 1.44

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood (2012) 1.43

Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol (2010) 1.42

Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med (2008) 1.41

TGF-beta induces IL-9 production from human Th17 cells. J Immunol (2010) 1.40

FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect (2009) 1.40

Th17 cells in immunity and autoimmunity. Clin Dev Immunol (2013) 1.40

Averting inflammation by targeting the cytokine environment. Nat Rev Drug Discov (2010) 1.36

C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol (2010) 1.34

Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun (2008) 1.32

Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin Exp Immunol (2009) 1.31

Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A (2010) 1.31

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol (2009) 1.30

T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol Rev (2009) 1.30

Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clin Exp Immunol (2009) 1.30

Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood (2011) 1.30

Interplay between effector Th17 and regulatory T cells. J Clin Immunol (2008) 1.29

The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol (2013) 1.29

Th17 response and inflammatory autoimmune diseases. Int J Inflam (2011) 1.29

Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol (2009) 1.26

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. Clin Exp Immunol (2011) 1.25

Plasticity of human CD4 T cell subsets. Front Immunol (2014) 1.25

Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun (2011) 1.23

A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum (2009) 1.23

Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol (2011) 1.22

The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol (2010) 1.21

Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol (2012) 1.21

Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells. Haematologica (2011) 1.20

Trial Watch: Immunostimulatory cytokines. Oncoimmunology (2012) 1.19

Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production. J Biol Chem (2011) 1.19

Articles cited by this

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29

Transforming growth factor-beta induces development of the T(H)17 lineage. Nature (2006) 25.91

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature (2007) 16.59

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol (2007) 16.21

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 14.28

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol (2007) 13.70

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity (2007) 13.29

Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol (2007) 12.76

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol (2007) 11.14

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem (2007) 4.77

The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol (2006) 2.98

Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A (2007) 2.92

T(H)-17 differentiation: of mice and men. Nat Immunol (2007) 2.40

Articles by these authors

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 46.36

IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol (2007) 12.20

Methods for high-density admixture mapping of disease genes. Am J Hum Genet (2004) 12.02

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med (2007) 11.82

A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med (2007) 10.00

Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature (2008) 9.32

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med (2004) 8.98

Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet (2007) 8.74

FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol (2010) 8.73

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol (2005) 7.80

Induction and effector functions of T(H)17 cells. Nature (2008) 7.75

Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 7.73

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet (2009) 7.16

Interleukin-17 and type 17 helper T cells. N Engl J Med (2009) 6.83

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med (2003) 6.73

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature (2002) 6.58

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med (2010) 6.24

A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol (2007) 6.20

The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat Immunol (2008) 5.92

Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med (2004) 5.13

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol (2003) 5.07

A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet (2005) 5.02

Automated high-dimensional flow cytometric data analysis. Proc Natl Acad Sci U S A (2009) 4.91

Th17: the third member of the effector T cell trilogy. Curr Opin Immunol (2007) 4.78

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc Natl Acad Sci U S A (2004) 4.75

Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature (2013) 4.74

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol (2003) 4.66

Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature (2013) 4.57

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A (2010) 4.56

Induction and molecular signature of pathogenic TH17 cells. Nat Immunol (2012) 4.43

Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet (2011) 4.42

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41

Reconstitution of contractile FtsZ rings in liposomes. Science (2008) 4.09

MHC class II expression identifies functionally distinct human regulatory T cells. J Immunol (2006) 4.06

The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol (2010) 4.06

Control of TH17 cells occurs in the small intestine. Nature (2011) 4.03

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature (2007) 3.92

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol (2009) 3.88

De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet (2009) 3.86

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science (2007) 3.70

Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature (2005) 3.62

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52

Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol (2009) 3.49

FtsZ in bacterial cytokinesis: cytoskeleton and force generator all in one. Microbiol Mol Biol Rev (2010) 3.47

CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol (2007) 3.39

Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol (2008) 3.37

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A (2005) 3.33

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A (2009) 3.31

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Blood (2011) 3.18

Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol (2003) 3.16

Human CD4+CD25+ regulatory T cells. Semin Immunol (2004) 3.13

IL-12 family cytokines: immunological playmakers. Nat Immunol (2012) 3.12

Dynamic regulatory network controlling TH17 cell differentiation. Nature (2013) 3.07

Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol (2009) 3.05

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2008) 3.04

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 3.04

IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood (2009) 3.04

Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest (2013) 3.03

TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol (2005) 3.00

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95

Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A (2010) 2.88

CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J Immunol (2005) 2.83

Th17 cells: effector T cells with inflammatory properties. Semin Immunol (2007) 2.81